BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

302 related articles for article (PubMed ID: 25174541)

  • 1. Leiomyosarcoma of the skin: clinical, histopathologic, and prognostic factors that influence outcomes.
    Winchester DS; Hocker TL; Brewer JD; Baum CL; Hochwalt PC; Arpey CJ; Otley CC; Roenigk RK
    J Am Acad Dermatol; 2014 Nov; 71(5):919-25. PubMed ID: 25174541
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Dermatofibrosarcoma protuberans: a report on 29 patients treated by Mohs micrographic surgery with long-term follow-up and review of the literature.
    Snow SN; Gordon EM; Larson PO; Bagheri MM; Bentz ML; Sable DB
    Cancer; 2004 Jul; 101(1):28-38. PubMed ID: 15221986
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Low recurrence rate after surgery for dermatofibrosarcoma protuberans: a multidisciplinary approach from a single institution.
    DuBay D; Cimmino V; Lowe L; Johnson TM; Sondak VK
    Cancer; 2004 Mar; 100(5):1008-16. PubMed ID: 14983497
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Mohs micrographic surgery for the treatment of cutaneous leiomyosarcoma.
    Starling J; Coldiron BM
    J Am Acad Dermatol; 2011 Jun; 64(6):1119-22. PubMed ID: 21571171
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Atypical intradermal smooth muscle neoplasms: clinicopathologic analysis of 84 cases and a reappraisal of cutaneous "leiomyosarcoma".
    Kraft S; Fletcher CD
    Am J Surg Pathol; 2011 Apr; 35(4):599-607. PubMed ID: 21358302
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A Systematic Review of the Treatment of Superficial Leiomyosarcoma With Mohs Micrographic Surgery.
    Murphy-Chutorian B; Routt E; Vinelli G; Ciocon D
    Dermatol Surg; 2019 Dec; 45(12):1437-1441. PubMed ID: 31397774
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Superficial leiomyosarcoma treated with Mohs micrographic surgery.
    Humphreys TR; Finkelstein DH; Lee JB
    Dermatol Surg; 2004 Jan; 30(1):108-12. PubMed ID: 14692939
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Primary cutaneous and subcutaneous leiomyosarcomas: evolution and prognostic factors.
    Aneiros-Fernandez J; Antonio Retamero J; Husein-Elahmed H; Ovalle F; Aneiros-Cachaza J
    Eur J Dermatol; 2016; 26(1):9-12. PubMed ID: 26678649
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cutaneous head and neck melanoma treated with Mohs micrographic surgery.
    Bricca GM; Brodland DG; Ren D; Zitelli JA
    J Am Acad Dermatol; 2005 Jan; 52(1):92-100. PubMed ID: 15627086
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Leiomyosarcoma of the skin. Treatment of 34 cases.
    Bernstein SC; Roenigk RK
    Dermatol Surg; 1996 Jul; 22(7):631-5. PubMed ID: 8680785
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Primary cutaneous leiomyosarcoma: clinicopathological analysis of 36 cases.
    Massi D; Franchi A; Alos L; Cook M; Di Palma S; Enguita AB; Ferrara G; Kazakov DV; Mentzel T; Michal M; Panelos J; Rodriguez-Peralto JL; Santucci M; Tragni G; Zioga A; Dei Tos AP
    Histopathology; 2010 Jan; 56(2):251-62. PubMed ID: 20102404
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Leiomyosarcoma: One disease or distinct biologic entities based on site of origin?
    Worhunsky DJ; Gupta M; Gholami S; Tran TB; Ganjoo KN; van de Rijn M; Visser BC; Norton JA; Poultsides GA
    J Surg Oncol; 2015 Jun; 111(7):808-12. PubMed ID: 25920434
    [TBL] [Abstract][Full Text] [Related]  

  • 13. "Low-grade leiomyosarcoma" and late-recurring smooth muscle tumors of the uterus: a heterogenous collection of frequently misdiagnosed tumors associated with an overall favorable prognosis relative to conventional uterine leiomyosarcomas.
    Veras E; Zivanovic O; Jacks L; Chiappetta D; Hensley M; Soslow R
    Am J Surg Pathol; 2011 Nov; 35(11):1626-37. PubMed ID: 21921786
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Dermatofibrosarcoma protuberans: wide local excision vs. Mohs micrographic surgery.
    Paradisi A; Abeni D; Rusciani A; Cigna E; Wolter M; Scuderi N; Rusciani L; Kaufmann R; Podda M
    Cancer Treat Rev; 2008 Dec; 34(8):728-36. PubMed ID: 18684568
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cutaneous leiomyosarcoma: dermal and subcutaneous.
    Wong GN; Webb A; Gyorki D; McCormack C; Tran P; Ngan SY; Slavin J; Henderson MA
    Australas J Dermatol; 2020 Aug; 61(3):243-249. PubMed ID: 32537765
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A Comparison of Mohs Micrographic Surgery and Wide Local Excision for Treatment of Dermatofibrosarcoma Protuberans With Long-Term Follow-up: The Mayo Clinic Experience.
    Lowe GC; Onajin O; Baum CL; Otley CC; Arpey CJ; Roenigk RK; Brewer JD
    Dermatol Surg; 2017 Jan; 43(1):98-106. PubMed ID: 27749444
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Primary cutaneous leiomyosarcoma: 32 cases].
    Auroy S; Contesso G; Spatz A; Genin J; Margulis A; Lecesne A; Avril MF
    Ann Dermatol Venereol; 1999 Mar; 126(3):235-42. PubMed ID: 10394436
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cutaneous leiomyosarcoma: a retrospective review of 45 cases.
    Khan S; Asher R; Perkins W; Matin RN
    Clin Exp Dermatol; 2023 Dec; 49(1):2-8. PubMed ID: 37595134
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Long-term outcomes of Mohs micrographic surgery for invasive melanoma of the trunk and proximal portion of the extremities.
    Burnett ME; Brodland DG; Zitelli JA
    J Am Acad Dermatol; 2021 Mar; 84(3):661-668. PubMed ID: 32763327
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Treatment outcome of superficial leiomyosarcoma.
    Wellings EP; Tibbo ME; Rose PS; Folpe AL; Houdek MT
    J Surg Oncol; 2021 Jan; 123(1):127-132. PubMed ID: 33063336
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.